Category Archives: Bayh Dole Act

Patent denied, price of prostate cancer drug may go down

The Indian Patent Office recently denied a patent for the drug Xtandi (Enzalutamide) by Japanese firm Astellas Pharma used in  treatment of prostate cancer. This decision comes in the light of the pre-grant opposition filed by pharma companies BDR Pharma, drug … Continue reading

Posted in Bayh Dole Act, March in rights, Patent, Patent Opposition, Sec 3 (d), Uncategorized | Tagged | Leave a comment

Just the Medicine

How the next president can lower drug prices with the stroke of a pen. By Alicia Mundy, Washington Monthly | Nov/Dec 2016 It’s hard to watch television or read a newspaper these days without seeing stories about outrageous prescription drug … Continue reading

Posted in Bayh Dole Act, Drug prices, Patent, R&D, Uncategorized | Leave a comment

Patent Law Holds Back Science

Bloomberg View; March 23, 2016. By Noah Smith. One of the biggest stories in science right now is the fight over the Crispr patents. Crispr is a gene editing technique that promises to allow previously unthinkable feats of bio-engineering. It was … Continue reading

Posted in Bayh Dole Act, Patents, Public research, Uncategorized | Leave a comment

NIH urged to ‘break taboo’ against using its power to bypass drug patents

Organizations echo Congress in demanding ‘march-in’ action from feds By Emily Wasserman, FiercePharma|January 14, 2016   The National Institutes of Health (NIH) has said that it would take “extraordinary” circumstances to use its little-known power to bypass certain drug patents. … Continue reading

Posted in Bayh Dole Act, Compulsory Licensing, Right to Health, Uncategorized | Leave a comment

Scientists call for a global R&D agreement

Members of the international academic and scientific community call upon the member states of the World Health Organisation (WHO) to negotiate a much overdue global research and development (R&D) agreement to ensure innovation and access to affordable vaccines, medicines and … Continue reading

Posted in Bayh Dole Act, Innovation, Transfer of Technology | Leave a comment

Stop Subsidizing Big Pharma

Source: New York Times January 5,2015 WASHINGTON — ROBERT J. BEALL, the president and chief executive of the Cystic Fibrosis Foundation, called his recent decision to sell the royalty rights to his organization’s research a “game changer.” Indeed: Deals like … Continue reading

Posted in Bayh Dole Act, Pricing | Leave a comment

15 frequently asked questions about the 2012-2013 ritonavir March-In petition

Source: KEI Q1. What is the Bayh-Dole Act? The Bayh-Dole Act (or University and Small Business Patent Procedures Act) was originally enacted in 1980 as Public Law 96-517, and was amended in 1984 by Public Law 98-620. Among other things, … Continue reading

Posted in Bayh Dole Act, IP Rights, Pricing, Right to Health | Tagged , , | Leave a comment